Yan H, Dhurjon L, Chow D R, Williams D, Chen J C
Department of Ophthalmology, Tianjin Medical University Hospital, Peoples Republic of China.
Ophthalmology. 1998 Sep;105(9):1612-6. doi: 10.1016/S0161-6420(98)99026-1.
This study aimed to report the occurrence of visual field defects after pars plana vitrectomy (PPV) for the treatment of each of the following conditions: macular hole (MH), subretinal neovascular membrane (SRNVM), and epiretinal membrane proliferation (EMP). This study also aimed to speculate on the pathogenic mechanisms for the observed field defects.
Noncomparative case series.
The study included 48 subjects (50 eyes). Twenty-one of the 50 eyes had stage III MH, 13 eyes had SRNVM, and 16 eyes had EMP.
Goldmann kinetic perimetry was performed postoperatively.
Visual field defects.
Nine (18%) of the 50 eyes had visual field defects. Four (19%) of the 21 eyes with MH and 5 (38%) of the 13 eyes with SRNVM had visual field defects. Of the 16 patients who had epiretinal membrane peeling, none had a visual field defect. An air-fluid exchange had been performed in all patients found to have a postvitrectomy field defect. The difference in rate of visual field defects in eyes that had air-fluid exchange (EMP group) was statistically significant (P < 0.05, chi-square). No significant correlation was found between visual field defect and preoperative intraocular pressure, postoperative intraocular pressure, patient's age, and iatrogenic detachment of the vitreous cortex. The field defects identified were altitudinal (2 eyes), baring of the blind spot (1 eye), inferotemporal (3 eyes), inferonasal (2 eyes), and superonasal (1 eye).
Central and peripheral visual field defects may occur after PPV for the treatment of MHs or SRNVMs. Air-fluid exchange procedure was the common denominator in all of the patients found to have visual field deficit. The etiology is likely to be trauma to the optic nerve region during the air-fluid exchange procedure.
本研究旨在报告玻璃体切除术(PPV)治疗以下每种疾病后视野缺损的发生情况:黄斑裂孔(MH)、视网膜下新生血管膜(SRNVM)和视网膜前膜增殖(EMP)。本研究还旨在推测观察到的视野缺损的致病机制。
非对照病例系列。
该研究纳入了48名受试者(50只眼)。50只眼中,21只患有III期MH,13只患有SRNVM,16只患有EMP。
术后进行Goldmann动态视野检查。
视野缺损。
50只眼中有9只(18%)出现视野缺损。21只患有MH的眼中有4只(19%)出现视野缺损,13只患有SRNVM的眼中有5只(38%)出现视野缺损。在16例行视网膜前膜剥除术的患者中,无一例出现视野缺损。所有发现有玻璃体切除术后视野缺损的患者均进行了气液交换。进行了气液交换的眼(EMP组)视野缺损发生率差异有统计学意义(P<0.05,卡方检验)。未发现视野缺损与术前眼压、术后眼压、患者年龄及医源性玻璃体皮质脱离之间存在显著相关性。所发现的视野缺损类型为:垂直性(2只眼)、盲点暴露(1只眼)、颞下(3只眼)、鼻下(2只眼)和鼻上(1只眼)。
PPV治疗MH或SRNVM后可能出现中央和周边视野缺损。气液交换操作是所有发现有视野缺损的患者的共同因素。病因可能是气液交换过程中对视神经区域的损伤。